<DOC>
	<DOC>NCT00357721</DOC>
	<brief_summary>The purpose of this clinical research study is to assess the pharmacokinetics of atazanavir administered twice-daily relative to historical data from atazanavir/ritonavir 300/100 mg, given once daily.</brief_summary>
	<brief_title>Atazanavir Twice Daily</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Healthy male and female subjects between the ages of 18 to 45 years old with a BMI of 18 to 30 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>